On March 30, 2017, Crowell & Moring’s Advertising & Product Risk Management Group hosted a webinar in which we discussed likely changes on the horizon at the Food & Drug Administration, Consumer Product Safety Commission, and the National Highway Traffic Safety Administration. We also discussed the relationship between these agencies and the Department of Justice, particularly with respect to enforcement trends.
The roundtable addressed what the regulated community can expect under the Trump Administration at the FDA, CPSC, and NHTSA. Our team engaged in a lively discussion highlighting where the agencies stand now in terms of appointments and leadership, and forecasting where policy might shift. Specifically, the panel focused on where, and how, the Trump Administration might affect current agency priorities including topical discussions of emerging products such as autonomous cars, and emerging issues including lithium ion batteries, as well as hacking concerns on interconnected products.
Please click here to access an on-demand recording of the webinar (note: you must complete the registration form for access).
Key Topics:
- Taking stock: Where are we now? What happens before new officials at the FDA, NHTSA, CPSC and DOJ are nominated and confirmed?
- Where and how will the Trump administration affect current agency priorities?
- Can autonomous vehicle technology and interconnected products thrive in the next four years? Any advantages or hurdles?
- Will we continue to see aggressive enforcement agendas at the agencies and how will the DOJ respond? How litigious will these agencies be in the coming months and years?
- What is the future of safety policy and rulemaking? Can these agencies met the EO requiring the repeal of two rules for every one promulgated? And what impact will the federal hiring freeze have on safety programs?